– Narrow-spectrum antibiotics – Gut microbiome preservation – Targeted antibiotic development – Inflammatory bowel disease – Molecular interaction prediction

Researchers at MIT and McMaster University have developed a new antibiotic called enterololin, designed to selectively target bacteria linked to Crohn’s disease flare-ups while preserving beneficial gut microbes. Traditional broad-spectrum antibiotics can disrupt the gut microbiome and worsen symptoms, searching for more precise treatments essential. Enterololin’s mechanism was rapidly identified using DiffDock, a generative AI … Read more